Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland

Published on :

Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland

CRB Launches SlateXpace, A Groundbreaking New Design-Build Solution for Life Science Facilities

SlateXpace by CRB
Published on :

CRB, a leading design-build firm specializing in tech and life science facilities, recently announced the launch of SlateXpace, a groundbreaking design-build solution for life science facilities. SlateXpace is a modular, multi-modal facility solution for the development and manufacture of Advanced Therapy Medicinal Products (ATMP) that offers life science organizations unprecedented construction speed, development flexibility, manufacturing adaptability, and budget control.